Table 4. Multivariable adjusted models exploring associations of individual SVD markers and different SVD scores and functional dependence * in CAA-related ICH patients .
OR (95% CI) | P value | |
---|---|---|
Model 1: individual SVD markers | ||
Age | 1.098 (0.983-1.226) | 0.097 |
Admission NIHSS | 1.211 (0.967-1.516) | 0.095 |
Hematoma volume | 0.985 (0.903-1.075) | 0.735 |
Lacunes | 0.349 (0.023-5.400) | 0.451 |
Lobar CMBs | 2.486 (0.360-17.156) | 0.355 |
Severe CSO-EPVS | 4.778 (0.568-400.125) | 0.150 |
WMH | 2.881 (0.234-35.407) | 0.408 |
cSS | 4.665 (1.388-15.679) | 0.013 |
Model 2: different total SVD scores | ||
Age | 1.120 (1.014-1.237) | 0.026 |
Admission NIHSS | 1.249 (0.979-1.594) | 0.074 |
Hematoma volume | 1.023 (0.935-1.120) | 0.617 |
The original SVD score | 0.129 (0.010-1.640) | 0.114 |
The modified SVD score | 3.816 (0.321-45.355) | 0.289 |
The refined SVD score | 0.802 (0.095-6.764) | 0.839 |
The CAA-SVD score | 3.429 (1.518-7.748) | 0.003 |
Total number of SVD markers | 1.410 (0.180-11.030) | 0.744 |
Abbreviation: SVD = Small Vessel Disease; CAA = Cerebral amyloid angiopathy; NIHSS = National Institutes of Health Stroke Scale; cSS = Cortical Superficial Siderosis; CMBs = Cerebral Microbleeds; WMH = White Matter Hyperintensities; EPVS = Enlarged Perivascular Spaces; CSO = Centrum Semiovale.
* Functional dependence was measured 3 months after onset and defined as the modified Rankin scale (mRS) >2